Suppr超能文献

肝豆状核变性脑萎缩的线性测量及临床相关性研究

A study of linear measurement and clinical correlation of brain atrophy in Wilson's disease.

作者信息

Wang Yun, Xuan Hongxia, Zhao Tun, Li Xiaodong, Li Shujuan, Hu Wenli

机构信息

Department of Neurology, Beijing Chaoyang Hospital, Capital Medical University, Beijing, China.

Department of Neurology, Hongda Hospital, Jiamusi University, Jiamusi, China.

出版信息

Front Hum Neurosci. 2023 Mar 28;17:1142082. doi: 10.3389/fnhum.2023.1142082. eCollection 2023.

Abstract

BACKGROUND

The aim of this study was to explore the clinical relevance of linear measures of Wilson's disease (WD).

METHODS

Relative values of brain atrophy in 30 patients with WD and 30 healthy volunteers were measured and compared using a manual measurement method. Linear measurement indicators of brain atrophy in patients with and without mental disorders were also compared. In addition, correlations of patients' age, disease duration, and Unified Wilson's Disease Rating Scale (UWDRS) scores with brain atrophy indicators were determined.

RESULTS

The results showed that the e-value, Huckman number, Evans index, and lateral ventricular body index were higher in the WD group compared with the control group. The age of patients with WD was negatively correlated with the -value and significantly positively correlated with the brainstem index. WD duration was prominently positively correlated with the d-value and negatively correlated with the -value. In addition, neurological function scores were significantly positively correlated with the c-value, -value, caudate nucleus index, Huckman number, Evans index, and lateral ventricular body index. By contrast, patients with psychiatric symptoms had a higher a-value and fourth ventricular index than those without psychiatric symptoms.

CONCLUSION

Therefore, it can be concluded that patients with WD and those with psychiatric symptoms have more severe brain atrophy compared to normal subjects. The patient's age, disease duration, and neurological function scores were positively correlated with the severity of brain atrophy.

摘要

背景

本研究的目的是探讨肝豆状核变性(WD)线性测量指标的临床相关性。

方法

采用手工测量方法,对30例WD患者和30名健康志愿者的脑萎缩相对值进行测量和比较。还比较了有精神障碍和无精神障碍患者的脑萎缩线性测量指标。此外,确定患者年龄、病程和统一肝豆状核变性评定量表(UWDRS)评分与脑萎缩指标的相关性。

结果

结果显示,与对照组相比,WD组的e值、赫克曼数、埃文斯指数和侧脑室体指数更高。WD患者的年龄与e值呈负相关,与脑干指数呈显著正相关。WD病程与d值显著正相关,与e值负相关。此外,神经功能评分与c值、e值、尾状核指数、赫克曼数、埃文斯指数和侧脑室体指数显著正相关。相比之下,有精神症状的患者比无精神症状的患者a值和第四脑室指数更高。

结论

因此,可以得出结论,与正常受试者相比,WD患者和有精神症状的患者脑萎缩更严重。患者的年龄、病程和神经功能评分与脑萎缩严重程度呈正相关。

相似文献

1
A study of linear measurement and clinical correlation of brain atrophy in Wilson's disease.
Front Hum Neurosci. 2023 Mar 28;17:1142082. doi: 10.3389/fnhum.2023.1142082. eCollection 2023.
2
Comparative assessment of clinical rating scales in Wilson's disease.
BMC Neurol. 2017 Jul 21;17(1):140. doi: 10.1186/s12883-017-0921-3.
3
Plasma neurofilament light chain as a biomarker in Wilson's disease.
Parkinsonism Relat Disord. 2022 Feb;95:5-10. doi: 10.1016/j.parkreldis.2021.12.003. Epub 2021 Dec 11.
4
Paramagnetic Metal Accumulation in the Deep Gray Matter Nuclei Is Associated With Neurodegeneration in Wilson's Disease.
Front Neurosci. 2020 Sep 16;14:573633. doi: 10.3389/fnins.2020.573633. eCollection 2020.
5
Topographical metal burden correlates with brain atrophy and clinical severity in Wilson's disease.
Neuroimage. 2024 Oct 1;299:120829. doi: 10.1016/j.neuroimage.2024.120829. Epub 2024 Sep 2.
6
Linear structural features of Wilson's disease and its correlation with neurological symptoms.
Medicine (Baltimore). 2022 Dec 16;101(50):e31386. doi: 10.1097/MD.0000000000031386.
7
Characteristics of neurological Wilson's disease with corpus callosum abnormalities.
BMC Neurol. 2019 May 3;19(1):85. doi: 10.1186/s12883-019-1313-7.
8
Optical coherence tomography as a marker of neurodegeneration in patients with Wilson's disease.
Acta Neurol Belg. 2017 Dec;117(4):867-871. doi: 10.1007/s13760-017-0788-5. Epub 2017 May 9.
9
Brain magnetic resonance imaging and severity of neurological disease in Wilson's disease - the neuroradiological correlations.
Neurol Sci. 2022 Jul;43(7):4405-4412. doi: 10.1007/s10072-022-06001-2. Epub 2022 Mar 11.
10
Metal deposits associated with brain atrophy in the deep gray matter nucleus in Wilson's disease.
Cereb Cortex. 2023 Jul 24;33(15):9223-9232. doi: 10.1093/cercor/bhad182.

引用本文的文献

1
Atrophy related neuroimaging biomarkers for neurological and cognitive function in Wilson disease.
Neurol Res Pract. 2025 Jul 1;7(1):47. doi: 10.1186/s42466-025-00401-3.

本文引用的文献

1
Measurement of the Brain Atrophy Index To Predict Mortality: a 'No-Brainer'?
Eur J Vasc Endovasc Surg. 2023 Mar;65(3):346-347. doi: 10.1016/j.ejvs.2022.12.023. Epub 2022 Dec 22.
2
Brain Atrophy Is Substantially Accelerated in Neurological Wilson's Disease: A Longitudinal Study.
Mov Disord. 2022 Dec;37(12):2446-2451. doi: 10.1002/mds.29229. Epub 2022 Sep 27.
3
Neuroimaging Correlates of Cognitive Deficits in Wilson's Disease.
Mov Disord. 2022 Aug;37(8):1728-1738. doi: 10.1002/mds.29123. Epub 2022 Jun 20.
5
Application of Evans Index in Normal Pressure Hydrocephalus Patients: A Mini Review.
Front Aging Neurosci. 2022 Jan 11;13:783092. doi: 10.3389/fnagi.2021.783092. eCollection 2021.
6
[Chinese guidelines for diagnosis and treatment of HIV/AIDS (2021 edition)].
Zhonghua Nei Ke Za Zhi. 2021 Dec 1;60(12):1106-1128. doi: 10.3760/cma.j.cn112138-20211006-00676.
7
Wilson's disease: update on pathogenesis, biomarkers and treatments.
J Neurol Neurosurg Psychiatry. 2021 Oct;92(10):1053-1061. doi: 10.1136/jnnp-2021-326123. Epub 2021 Aug 2.
8
Brain Atrophy Is a Better Biomarker than Susceptibility for Evaluating Clinical Severity in Wilson Disease.
Radiology. 2021 Jun;299(3):673-674. doi: 10.1148/radiol.2021210106. Epub 2021 Mar 23.
9
Associations of Brain Atrophy and Cerebral Iron Accumulation at MRI with Clinical Severity in Wilson Disease.
Radiology. 2021 Jun;299(3):662-672. doi: 10.1148/radiol.2021202846. Epub 2021 Mar 23.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验